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Abstract
Background: Anorexia nervosa is a severe psychosomatic disease with somatic complications in the long-term
course and a high mortality rate. Somatic comorbidities independent of anorexia nervosa have rarely been studied,
but pose a challenge to clinical practitioners. We investigated somatic comorbidities in an inpatient cohort and
compared somatically ill anorexic patients and patients without a somatic comorbidity. In order to evaluate the
impact of somatic comorbidity for the long-term course of anorexia nervosa, we monitored survival in a long-term
follow-up.
Method: One hundred and sixty-nine female inpatients with anorexia nervosa were treated at the Charité
University Medical Centre, Campus Benjamin Franklin, Berlin, between 1979 and 2011. We conducted retrospective
analyses using patient’s medical and psychological records. Information on survival and mortality were required
through the local registration office and was available for one hundred patients. The mean follow-up interval for
this subgroup was m = 20.9 years (sd = 4.7, min = 13.3, max = 31.6, range = 18.3). We conducted survival analysis
using cox regression and included somatic comorbidity in a multivariate model.
Results: N = 41 patients (24.3%) showed a somatic comorbidity, n = 13 patients (7.7%) showed somatic
comorbidities related to anorexia nervosa and n = 26 patients (15.4%) showed somatic comorbidities independent
of anorexia nervosa, n = 2 patients showed somatic complications related to other psychiatric disorders. Patients
with a somatic comorbidity were significantly older (m = 29.5, sd = 10.3 vs m = 25.0, sd = 8.7; p = .006), showed a
later anorexia nervosa onset (m = 24.8, sd = 9.9 vs. m = 18.6, sd = 5.1; p < .000) and a longer duration of
treatment in our clinic (m = 66.6, sd = 50.3 vs. m = 50.0, sd = 47; p = .05) than inpatients without somatic
comorbidity. Out of 100 patients, 9 patients (9%) had died, on average at age of m = 37 years (sd = 9.5). Mortality
was more common among inpatients with somatic comorbidity (n = 6, 66.7%) than among inpatients without a
somatic disease (n = 3, 33.3%; p = .03). Somatic comorbidity was a significant coefficient in a multivariate survival
model (B = 2.32, p = .04).
Conclusion: Somatic comorbidity seems to be an important factor for anorexia nervosa outcome and should be
included in multivariate analyses on the long-term course of anorexia nervosa as an independent variable. Further
investigations are needed in order to understand in which way anorexia nervosa and a somatic disease can
interact.
Keywords: anorexia nervosa, long-term course, somatic comorbidity, mortality
* Correspondence: Laurence.erdur@charite.de
1Department of Psychosomatic Medicine and Psychotherapy, Charité
Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany
Full list of author information is available at the end of the article
Erdur et al. BioPsychoSocial Medicine 2012, 6:4
http://www.bpsmedicine.com/content/6/1/4
© 2012 Erdur et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Background
Anorexia nervosa is a severe psychosomatic disease with
a lifetime prevalence of 1.2%-2.2% [1]. The Standardized
Mortality Ratio (SRM) for anorexia nervosa is 5.9, as
recently published meta-analyses showed [2]. Thus,
anorexia nervosa is the psychosomatic disease with the
highest rate of mortality. Severe somatic complications
related to poor outcome of anorexia nervosa (eg. osteo-
porosis, renal insufficiency) have been observed in the
long-term course [3,4]. These somatic complications
result from the anorexia inherent symptoms, such as
permanent underweight, amenorrhoea or purging beha-
viour. However, little is known about the course of ill-
ness in patients who suffer from a somatic disease
independent from anorexia nervosa, such as chronic
internal diseases like diabetes mellitus or inflammatory
bowel diseases. This subgroup of anorexic patients is
mostly excluded in empirical follow-up studies in order
to create homogeneous samples. Apart from case
r e p o r t s[ 5 - 7 ] ,w ef o u n do n l yo n ee m p i r i c a ls t u d yi n
which this specific subgroup of patients was mentioned
[8] which reported a very poor long-term prognosis and
a high mortality rate. In clinical practice, these patients
require intensive and integrative care where interacting
effects of the somatic and psychosomatic disease consti-
tute a major challenge for therapeutic interventions.
Summing up the existing case reports on anorexia
nervosa patients with a comorbid somatic disease, the
following possible mechanisms of interaction can be
derived:
■ Anorexia nervosa patients often show low compli-
ance and denial of illness [9]. This might also com-
plicate the treatment of a somatic disease (e. g.
Asthma, [10])
■ Anorexia nervosa symptoms, such as permanent
underweight, influence the immune system and lead
to frequent infections (e. g. Tuberculosis; [11])
■ The psychological (mal-) adaptation to the onset
of a somatic disease can trigger the development of
anorexia nervosa (e. g. Diabetes mellitus type one;
[12])
■ A somatic disease related to weight changes or
alterations in food intake can “hide” a comorbid eat-
ing disorder (e. g. Crohn’s disease; [7])
■ Somatic complications resulting from anorexia
nervosa aggravate the course of a somatic disease (e.
g. Lupus erythematodes; [6])
Until now, it is not clear which role somatic comor-
bidity plays in the long-term course of anorexia nervosa,
since it is not known which somatic diseases most fre-
quently co-occur with anorexia nervosa and if there are
specific features for these patients. Therefore, we investi-
gated basic clinical characteristics and somatic comor-
bidity of anorexic inpatients during psychosomatic
therapy and monitored survival and mortality in a long-
term follow-up.
Method
Sample
One hundred and sixty-nine consecutive female inpati-
ents with a consensus diagnosis of anorexia nervosa
according to DSM-IV criteria were treated between
1979 and 2010 at the psychosomatic department of the
Charité University Medical Centre, Campus Benjamin
Franklin, Berlin. The mean age was m = 6.2 years (sd =
9.3), the mean body mass index (BMI) at admission was
m = 15.2 (sd = 2.1). N = 90 patients (53.3%) showed the
purging and n = 74 (43.8%) the restrictive anorexia ner-
vosa subtype. The mean duration of illness at first pre-
sentation in our clinic was m = 6.3 years (sd = 7.6).
Treatment
All patients followed the same psychosomatic treatment,
focusing on acute psychological and somatic stabiliza-
tion: Beside internal medical diagnostic and therapeutic
measurements for stabilization of weight and eating
behaviour, and p.e. normalization of electrolytes, we
applied individual and group therapy, art therapy, con-
centrative movement therapy, and relaxation. On aver-
age, the treatment took m = 54.2 days (sd = 48.2).
Instruments
We conducted retrospective analyses using differentiated
medical and psychological records of the patients from
the beginning of inpatient treatment (T0). Medical data
included somatic comorbidities, medication, blood test
results, and standardized measurements of weight and
height. Psychological records provided data on duration
and onset of illness, socio-demographic data and psy-
chiatric comorbidity.
Assessment of mortality
Data on mortality were required through the appropri-
ate registration office between 2010 and 2011 (T1). At
time of publication, data on N = 100 patients was avail-
able. The mean follow-up interval for this sample was m
= 20.9 years (sd = 4.8).
Statistical analysis
We conducted parametric tests such as the Students T-
Tests for independent samples or the Chi
2-Test for
nominal scaled data. For mortality, we conducted survi-
val analysis using cox regression and included somatic
comorbidity as an independent variable in a multivariate
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criterion p < .05). Calculations were done with SPSS
19.0. Coefficients are considered significant if the
respective p-values are less than a = 0.05.
Ethical approval
The study was approved by the local ethical committee
of the Charité University Medical Centre, Campus Ben-
jamin Franklin, Berlin, Germany (application number
EA4/073/08).
Results
Somatic comorbidity
Somatic comorbidity at T0 was present in N = 41
patients (24.3%). N = 13 patients (7.7%) showed somatic
comorbidities related to anorexia nervosa, predomi-
nantly internal diseases (n = 9). N = 26 patients (15.4%),
showed somatic comorbidities independent of anorexia
nervosa, also most frequently in the field of internal
medicine (n = 9). N = 2 patients showed somatic com-
plications related to other psychiatric disorders (one
case with abscesses due to an artificial disorder and one
case with hepatitis resulting from chronic alcohol
abuse). Somatic comorbidities are presented in table 1.
Specific features of anorexia nervosa inpatients with and
without somatic comorbidity
At T0, anorexia nervosa inpatients with somatic comor-
bidity were significantly older (m = 29.5, sd = 10.3) than
inpatients without a somatic comorbidity (m = 25.0, sd
= 8.7; p = .006), showed a later anorexia nervosa onset
(m = 24.8, sd = 9.9 vs. m = 18.6, sd = 5.1; p < .000) and
a longer duration of treatment in our clinic (m = 66.6,
sd = 50.3 vs. m = 50.0, sd = 47; p = .05). No differences
were observed with regard to BMI at admission, BMI
change during treatment or duration of anorexia ner-
vosa before presentation in our clinic. Education status
did not differ between groups, nor did psychiatric
comorbidity. No differences were observed for frequen-
cies of anorexia nervosa subtype. See table 2 for detailed
statistics.
Mortality
At time of publication, data on 100 patients treated
between 1979 and 1997 was available. Out of these 100
patients, 9 patients (9%) had died. Age of death was m
= 37.0 years (sd = 9.5, range 19.6 - 46.6 years), and the
interval between end of treatment in our department
and death was m = 7.9 years (sd = 7.2). One patient
died shortly after discharge (the patient refused to con-
tinue the psychosomatic treatment and left our clinic
against medical advice; see Köpp et al. for a detailed
case report [13]). Mortality was significantly more com-
mon among inpatients with somatic comorbidity (n = 6,
66.7%) than among inpatients without a somatic disease
(n = 3, 33.3%; p = .03). Mortality was also associated
with higher frequencies of substance abuse (n = 4,
44.4% vs. n = 11, 13.3%; p = .02; laxative use is not
included). No differences with regard to age at T0, onset
of illness, purging behaviour, BMI at admission or
weight gain during treatment were observed. See table 3
for detailed statistics and Figure 1 for results of the sur-
vival analyses.
Table 1 Somatic comorbidities in N = 169 female
inpatients with anorexia nervosa
Somatic comorbidities related to anorexia nervosa
n%
Internal Medicine 9 5.3 Nephropathie (1)
Renal insufficiency (2)
Sinus Tachycardia (1)
Mitral valve prolapse (1)
Endocarditis (1)
Alimentary gastritis (1)
Ileus (1),
Duodenitis (1)
Dentistry 1 0.6 Multiple Dental Destructions (1)
Orthopaedy 3 1.8 Osteoporosis (3)
Total 13 7.7
Somatic comorbidities independent of anorexia nervosa
n%
Internal Medicine 13 7.7 Asthma (3)
COPD (1)
Diabetes mellitus Type 1 (2)
EBV Infection (1)
Ulcera ventriculi (1)
Inflammatory Bowel Diseases (3)
Thalassemia (1)
Nephrolithiasis (1)
Dermatology 7 4.1 Atopy (2)
Eczema (1)
Urticaria (1)
Tinea pedis (1)
Keratosis (1)
Psoriasis (1)
Gynaecology 1 0.6 Polycystic Ovary Syndrome (1)
Haematology 2 1.2 Breast Cancer (1)
Anal Cancer (1)
Neurology 1 0.6 Epilepsy (1)
Othopaedy 3 1.8 Comminuted Fracture (1)
Scoliosis (1)
Hip Dysplasia (1)
Total 26 15.4
Somatic comorbidities related to (other) psychiatric disorders
n%
Surgery 1 0.6 Abscesses (Artificial Disorder)
Internal Medicine 1 0.6 Hepatitis (toxic, related to alcohol abuse)
Total 2 1.2
Total 41 24.3
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comorbidity proved to be significant (B = 2.32, p = .04)
and was included as the only significant coefficient vari-
able in a significance model (Chi
2 =6 . 6 ,p=. 0 2 )u s i n g
stepwise inclusion of eleven parameters (excluded: age
at T0, duration of treatment, BMI at T0,B M Ig a i nd u r -
ing treatment, onset of anorexia nervosa, duration of
anorexia nervosa at T0, psychiatric comorbidity, sub-
stance abuse, type of anorexia nervosa restrictive/
purging).
Discussion
In our clinical study on 169 female anorexia nervosa
inpatients, we found 24.3% of the patients with a comor-
bid somatic disease. These diseases were partly related
(7.7%) and more frequently unrelated (15.4%) to anor-
exia nervosa. For both subgroups, internal diseases were
observed most frequently. Overall, diverse somatic
comorbidities from different medical fields were
reported. Somatically ill anorexia nervosa patients
showed higher age at the time of treatment, a later
onset of anorexia nervosa and had a longer duration of
treatment. Mortality was observed in nine of one hun-
dred patients and was significantly higher in somatically
ill patients. The relationship between mortality and
somatic comorbidity was also statistically shown in a
survival analysis, revealing somatic comorbidity as a sig-
nificant coefficient.
The small sample of deceased anorexia nervosa inpati-
ents did not allow us to conduct more sophisticated
Table 2 Specific features of anorexia nervosa inpatients with and without somatic comorbidity
ms d p
Age at admission (T0) AN* with somatic comorbidity 29.5 10.3 .006**
AN without somatic comorbidity 25.0 8.7
Duration of treatment (days) AN with somatic comorbidity 66.6 50.3 .05*
AN without somatic comorbidity 50.0 47.0
BMI at admission (T0) AN with somatic comorbidity 14.8 1.8 ns
AN without somatic comorbidity 15.3 2.1
BMI change during treatment AN with somatic comorbidity 0.7 1.2 ns
AN without somatic comorbidity 0.6 0.9
Age at onset of AN AN with somatic comorbidity 24.8 9.9 < .000***
AN without somatic comorbidity 18.6 5.1
Duration of AN (T0) AN with somatic comorbidity 5.1 6.6 ns
AN without somatic comorbidity 6.7 7.8
Subtype of AN
restrictive AN with somatic comorbidity 17 41.5% ns
AN without somatic comorbidity 57 46.3%
purging AN with somatic comorbidity 24 58.5%
AN without somatic comorbidity 66 53.7%
Psychiatric comorbidity
Depressive disorders AN with somatic comorbidity 11 39.3% ns
AN without somatic comorbidity 28 45.2%
Anxiety disorders AN with somatic comorbidity 6 21.4% ns
AN without somatic comorbidity 12 19.4%
OCD** AN with somatic comorbidity 4 14.3% ns
AN without somatic comorbidity 5 7.9%
Personality Disorders AN with somatic comorbidity 3 27.3% ns
AN without somatic comorbidity 7 43.8%
Substance Abuse AN with somatic comorbidity 5 17.2% ns
AN without somatic comorbidity 10 16.1%
Total AN with somatic comorbidity 16 38.1% ns
AN without somatic comorbidity 33 26.0%
*AN: Anorexia nervosa
**OCD: Obsessive Compulsive Disorder
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val analyses. The interpretation and generalization of
our results is limited. No information on the causes of
death was available for us. Therefore, we cannot draw
confident causal conclusions between the observed cor-
relation of mortality and somatic comorbidity.
The relatively high rate of somatically ill anorexia ner-
vosa inpatients can be explained with the specific refer-
ral procedure to our university medical centre.
Moreover, the intensive cooperation between our psy-
chosomatic department and other units, such as the gas-
troenterological, neurological, and endocrinological
departments, probably led to frequent referrals of
patients with somatic illnesses.
Long-term mortality in anorexia nervosa has been
intensively studied, and mortality rates vary together
with the follow-up interval [2]. Data on the outcome of
anorexia nervosa after more than 15 years is rare, and
our follow-up interval of 21 years can be considered as
relatively long. The observed mortality rate in our sam-
ple is in the rage of mortality rates to be expected with
regard to the existing literature. However, we cannot
confirm the reported correlations of laxative use/purging
behaviour, BMI, duration of illness/onset, and psychia-
tric comorbidity. We only can confirm the relationship
between substance abuse and mortality, which has also
often been described in former studies [2]. The reason
Table 3 Specific features of N = 100 anorexia nervosa
inpatients in a 21-year follow-up (N = 91 alive and N = 9
deceased)
ms d p
Age at admission (T0) Alive 23.5 5.7 ns
Deceased 29.0 9.0
Duration of treatment (days) Alive 75.7 40.7 ns
Deceased 60.3 50.1
BMI at admission (T0) Alive 14.9 1.9 ns
Deceased 15.8 2.4
BMI change during treatment Alive 0.8 1.1 ns
Deceased 0.3 1.7
Age at onset of anorexia nervosa Alive 19.4 4.6 ns
Deceased 26.0 10.1
Duration of anorexia nervosa (T0) Alive 3.8 4.2 ns
Deceased 3.8 2.7
Purging Behaviour N %
Alive 58 67.4% ns
Deceased 7 87.5%
Psychiatric comorbidity Alive 43 47.8% ns
Deceased 6 66.7%
Substance abuse Alive 11 13.3% .02*
Deceased 4 44.4%
Somatic comorbidity Alive 25 27.8% .03*
Deceased 6 66.7%
Figure 1 Survival in 100 female inpatients with anorexia nervosa. somatic comorbidity. no somatic comorbidity.
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sample.
To our knowledge, the present study is the first
empirical sample that describes anorexia nervosa inpati-
ents with a somatic comorbidity. The correlation with
mortality might at least indicate a poor outcome for
inpatients in this subsample, which confirms the clinical
impression of medical practitioners treating anorexia
nervosa patients. The relatively high co-occurrence of
anorexia nervosa and somatic diseases in all medical
fields is probably an issue that medical professionals are
not overly aware of in clinical practice. Especially, in
cases of patients where the somatic disease is associated
with alterations in food intake and weight, such as
inflammatory bowel diseases, medical professionals may
not consider the possible existence of a comorbid anor-
exia nervosa. Moreover, we observed a high age and a
late onset of anorexia nervosa in this subgroup, features
that may not “fit” into the clinical idea medical practi-
tioners have of the “typical” anorexic individual. The
high rate of mortality in this group could reflect the
“result” of this supposed problematic constellation.
To assure a good therapeutic outcome for anorexia
nervosa patients with a somatic comorbidity, a high
level of interdisciplinary treatment including all medical
fields and early interventions by professionals in the
field of psychosomatic medicine is needed. This group
of patients might be at a specific risk for particularly
poor long-term outcome. Further studies are needed to
confirm these findings.
Conclusion
Anorexia nervosa patients with a somatic comorbidity
pose a challenge to medical professionals and might be
at risk for poor long-term outcome. Further long-term
studies on anorexia nervosa should include somatic
comorbidity as an independent variable in a multivariate
design.
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